Understand peptides. Read the research in context.
Learn what peptides are, what researchers have actually studied, and where the evidence still has limits.
No peptide is a magic solution or completely free of risk. Better decisions begin with clear information, realistic expectations, and qualified medical guidance.
The library.
Ten short evidence notes, grouped by how much research stands behind them. Each note carries an evidence tier and a reading time.
Education only, not medical advice. Talk to a licensed clinician. See what the research looked at
Human trial evidence
Compounds with published human trials, none approved for performance use.
SS-31 (Elamipretide)
What it is
A tetrapeptide that targets mitochondria and is studied for inner mitochondrial membrane function and oxidative stress.
What has been studied
Human trials exist in mitochondrial disease and related indications. It is not an approved tool for gym performance or body composition.
Retatrutide
What it is
An investigational triple agonist (GIP / GLP-1 / glucagon) studied for appetite, glycemic control, and weight reduction.
What has been studied
Phase 2/3 obesity trials show large weight reduction effects. Not approved by FDA. Any use is a licensed prescriber decision, not coaching.
Semax
What it is
An analog of an ACTH fragment studied for neurotrophic signaling, attention, and neuroprotection.
What has been studied
Used clinically in Russia with human studies. Western randomized evidence for cognitive or training use is limited.
Regulatory status (Oct 28, 2026): Covered by an HHS interim enforcement-discretion policy for licensed 503A pharmacies, with prescription and sourcing conditions. Not approved by FDA. Education only, not medical advice. Talk to a licensed clinician.
Preclinical and early research
Mostly cell and animal work, with little controlled human data.
MOTS-c
What it is
A peptide derived from mitochondria and studied for AMPK signaling and metabolic flexibility in cells and animals.
What has been studied
Most published work is rodent or in vitro. Controlled human efficacy trials for training or fat loss are not established.
Regulatory status (Oct 28, 2026): Covered by an HHS interim enforcement-discretion policy for licensed 503A pharmacies, with prescription and sourcing conditions. Not approved by FDA. Education only, not medical advice. Talk to a licensed clinician.
GHK-Cu
What it is
A tripeptide that binds copper and is studied for collagen signaling, tissue remodeling, and topical cosmetic use.
What has been studied
Strongest literature is cosmetic and related to wound care. Independent, controlled human evidence for systemic athletic recovery is thin.
BPC-157
What it is
A gastric pentadecapeptide studied in animals for tendon, gut, and soft tissue models.
What has been studied
The gap between online claims and evidence is wide: rodent data, no adequate human efficacy RCT. Athletes should know quality in the unregulated market is uncertain.
Regulatory status (Oct 28, 2026): Covered by an HHS interim enforcement-discretion policy for licensed 503A pharmacies, with prescription and sourcing conditions. Not approved by FDA. Education only, not medical advice. Talk to a licensed clinician.
Banned in sport by WADA.
KPV
What it is
A tripeptide fragment of alpha-MSH studied for inflammation and gut barrier signaling.
What has been studied
Most data are cell and animal models. Controlled human outcomes for training or gut repair are not in place.
Regulatory status (Oct 28, 2026): Covered by an HHS interim enforcement-discretion policy for licensed 503A pharmacies, with prescription and sourcing conditions. Not approved by FDA. Education only, not medical advice. Talk to a licensed clinician.
Epitalon
What it is
A tetrapeptide analog associated with pineal signaling, melatonin rhythm, and telomere claims.
What has been studied
Published work clusters around one research group. Independent replication for longevity or sleep in healthy athletes is weak.
Regulatory status (Oct 28, 2026): Covered by an HHS interim enforcement-discretion policy for licensed 503A pharmacies, with prescription and sourcing conditions. Not approved by FDA. Education only, not medical advice. Talk to a licensed clinician.
Unregulated market
Products sold online whose identity and evidence are uncertain.
TB-500
What it is
Sold as an acetylated fragment of thymosin beta 4, discussed for cell migration and soft tissue repair.
What has been studied
Full-length thymosin beta 4 has a research record; the product called TB-500 is a different, poorly standardized article. Human efficacy for the sold fragment is not established.
Regulatory status (Oct 28, 2026): Covered by an HHS interim enforcement-discretion policy for licensed 503A pharmacies, with prescription and sourcing conditions. Not approved by FDA. Education only, not medical advice. Talk to a licensed clinician.
Banned in sport by WADA.
Often grouped, not peptides
Compounds discussed alongside peptides that are chemically different.
NAD+
What it is
A coenzyme in redox and sirtuin pathways, not a peptide. Often grouped with this conversation by clinics, not by chemistry.
What has been studied
Human work mostly involves precursors (NR, NMN) or IV protocols. Results vary; this is not a peptide education item in the strict sense.
What the research looked at.
One published study for each peptide in the library: who or what was studied, how, and what the authors reported. A single study is a window into the literature, not a verdict.
Education only, not medical advice. Talk to a licensed clinician.
Prescription medicines
- InsulinHuman RCT
- What it is
- A hormone made by the pancreas that lets cells take up sugar from the blood.
- Used for
- US prescription medicine for blood sugar management in diabetes.
- Studied for
- Blood sugar levels in type 1 diabetes (human RCT)
- Diabetic eye, kidney and nerve complications (human RCT)
- Made of
- 51 amino acids in two chains (21 and 30) joined by disulfide bonds.
- What research found
- In the DCCT, a trial of 1,441 people with type 1 diabetes followed for about 6.5 years, researchers reported that intensive insulin therapy was associated with a 76% lower adjusted risk of developing eye damage (retinopathy) and fewer kidney and nerve complications, with a two- to threefold rise in severe low blood sugar.
Diabetes Control and Complications Trial Research Group; Nathan DM, et al. N Engl J Med. 1993;329(14):977-986. PMID 8366922 · DOI 10.1056/NEJM199309303291401
- LiraglutideHuman RCT
- What it is
- A lab-made, longer-lasting version of the gut hormone GLP-1.
- Used for
- US prescription medicine for type 2 diabetes (Victoza) and chronic weight management (Saxenda).
- Studied for
- Body weight in adults without diabetes (human RCT)
- Major heart events in type 2 diabetes (human RCT)
- Made of
- 31 amino acids, 97% matching natural GLP-1, with a fatty-acid chain attached so it lasts longer in the blood.
- What research found
- In the SCALE trial of 3,731 adults without diabetes, researchers reported an average body-weight change of −8.4 kg over 56 weeks versus −2.8 kg with placebo. In the LEADER trial of 9,340 people with type 2 diabetes, researchers reported major heart events in 13.0% versus 14.9% with placebo.
Pi-Sunyer X, et al. N Engl J Med. 2015;373(1):11-22. PMID 26132939 · DOI 10.1056/NEJMoa1411892
- SemaglutideHuman RCT
- What it is
- A once-weekly, lab-made version of the gut hormone GLP-1.
- Used for
- US prescription medicine for type 2 diabetes (Ozempic) and for chronic weight management and cardiovascular risk in certain adults (Wegovy).
- Studied for
- Body weight in adults without diabetes (human RCT)
- Major heart events in adults with heart disease and overweight (human RCT)
- Made of
- 31 amino acids, 94% matching natural GLP-1, with two swapped building blocks and a fatty-acid chain that binds blood proteins.
- What research found
- In STEP 1, a trial of 1,961 adults without diabetes, researchers reported an average 14.9% body-weight reduction over 68 weeks versus 2.4% with placebo. In SELECT, a trial of 17,604 adults with heart disease and overweight, major heart events occurred in 6.5% versus 8.0% with placebo.
Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002. PMID 33567185 · DOI 10.1056/NEJMoa2032183
- TirzepatideHuman RCT
- What it is
- A once-weekly lab-made peptide that acts on two gut-hormone receptors, GIP and GLP-1.
- Used for
- US prescription medicine for type 2 diabetes (Mounjaro) and for chronic weight management and obstructive sleep apnea in adults with obesity (Zepbound).
- Studied for
- Body weight in adults without diabetes (human RCT)
- Share of participants with at least 5% weight change (human RCT)
- Made of
- 39 amino acids based on the hormone GIP, with two non-standard building blocks and a fatty-acid chain.
- What research found
- In SURMOUNT-1, a trial of 2,539 adults without diabetes, researchers reported average weight reductions of 15.0% to 20.9% across three dose groups over 72 weeks, versus 3.1% with placebo.
Jastreboff AM, et al. N Engl J Med. 2022;387(3):205-216. PMID 35658024 · DOI 10.1056/NEJMoa2206038
- OxytocinHuman RCT
- What it is
- A natural hormone released by the pituitary gland, involved in childbirth and breastfeeding.
- Used for
- US prescription medicine (Pitocin) used in labor and after delivery. Researchers have also studied it in autism.
- Studied for
- Social functioning in children with autism (human RCT; no difference from placebo)
- Labor and after-delivery use (approved uses)
- Made of
- 9 amino acids, with a ring formed by a bond between two cysteines.
- What research found
- In a 24-week trial of 290 children and adolescents with autism, researchers reported no difference from placebo on social withdrawal or other social and cognitive measures; side effects were similar in both groups. This is a negative result.
Sikich L, et al. N Engl J Med. 2021;385(16):1462-1473. PMID 34644471 · DOI 10.1056/NEJMoa2103583
- PT-141 (Bremelanotide)Human RCT
- What it is
- A lab-made peptide that acts on melanocortin receptors in the brain.
- Used for
- US prescription medicine (Vyleesi) for hypoactive sexual desire disorder (HSDD) in premenopausal women.
- Studied for
- Sexual desire scores in premenopausal women with HSDD (human RCTs)
- Distress about low desire (human RCTs)
- Made of
- 7 building blocks; six form a ring, and it includes non-standard and mirror-image amino acids.
- What research found
- In two phase 3 trials (RECONNECT) of 1,267 premenopausal women, researchers reported statistically significant increases in sexual desire and reductions in related distress versus placebo over 24 weeks. Nausea, flushing and headache were more common with bremelanotide.
Kingsberg SA, et al. Obstet Gynecol. 2019;134(5):899-908. PMID 31599840 · DOI 10.1097/AOG.0000000000003500
Human trial evidence
- SS-31 (Elamipretide)Human RCT
- What it is
- A small lab-made peptide that targets mitochondria, the energy-producing parts of cells.
- Used for
- US prescription medicine since September 19, 2025 (Forzinity), under FDA accelerated approval, for muscle strength in Barth syndrome in patients 30 kg or more; continued approval depends on a confirmatory trial. Researchers have also studied it in primary mitochondrial myopathy.
- Studied for
- Walking distance in mitochondrial myopathy (human RCT; no difference from placebo)
- Fatigue in mitochondrial myopathy (human RCT; no difference from placebo)
- Knee muscle strength in Barth syndrome (12-patient crossover trial; basis of accelerated approval)
- Made of
- 4 amino acids, including a modified tyrosine and a mirror-image arginine.
- What research found
- In MMPOWER-3, a trial of 218 adults with primary mitochondrial myopathy, researchers reported no difference between elamipretide and placebo in walking distance or fatigue over 24 weeks. The Barth syndrome accelerated approval rests on knee muscle strength, an intermediate measure, from a separate 12-patient crossover trial.
- Status
- Products sold online as 'SS-31' are not the approved medicine.
Karaa A, et al. Neurology. 2023;101(3):e238-e252. PMID 37268435 · DOI 10.1212/WNL.0000000000207402
- RetatrutideHuman RCT
- What it is
- An investigational once-weekly peptide that acts on three hormone receptors: GIP, GLP-1 and glucagon.
- Used for
- Investigational. Researchers are studying it in obesity and type 2 diabetes. Not approved by FDA.
- Studied for
- Body weight in adults with obesity or overweight (human phase 2 RCT; investigational)
- Share of participants with at least 10% or 15% weight change (human phase 2 RCT)
- Made of
- A 39-amino-acid backbone with chemical modifications that extend its action.
- What research found
- In a phase 2 trial of 338 adults with obesity or overweight, the primary endpoint was weight change at 24 weeks; researchers reported average reductions of up to 24.2% at 48 weeks (a secondary endpoint) in the highest-dose group, versus 2.1% with placebo. Gastrointestinal effects and heart-rate increases rose with dose.
- Status
- Investigational; not approved by FDA.
Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526. PMID 37366315 · DOI 10.1056/NEJMoa2301972
- SemaxHuman controlled trial
- What it is
- A lab-made peptide based on a fragment of the stress hormone ACTH.
- Used for
- Registered as a medicine in Russia for stroke and certain brain-circulation and cognitive conditions. Not approved in the US.
- Studied for
- Neurological function after ischemic stroke (non-randomized human study)
- Brain electrical activity (EEG) after stroke (non-randomized human study)
- Made of
- 7 amino acids: a 4-amino-acid piece of ACTH plus a Pro-Gly-Pro tail.
- What research found
- In a Russian study of 30 patients in the early phase of ischemic stroke, compared with 80 patients on standard care alone (not randomized), researchers reported somewhat faster recovery of neurological function, especially movement. The article is in Russian.
- Status
- Not approved for human use in the US.
Gusev EI, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(6):26-34. PMID 11517472
- CJC-1295Human RCT
- What it is
- A lab-made, long-acting version of growth hormone-releasing hormone (GHRH).
- Used for
- Researchers studied its effect on growth hormone levels. It is not an approved medicine.
- Studied for
- Growth hormone and IGF-I levels (human RCTs in healthy adults)
- How long it stays in the blood (human RCTs; half-life 5.8 to 8.1 days)
- Made of
- A modified 29-amino-acid fragment of GHRH with a chemical linker that attaches to albumin in the blood, extending its life to several days.
- What research found
- In two randomized, placebo-controlled trials in healthy adults aged 21 to 61, researchers reported dose-dependent rises in growth hormone (2- to 10-fold) and IGF-I (1.5- to 3-fold) lasting several days after a single administration, and no serious adverse reactions.
- Status
- Not approved for human use in the US.
Teichman SL, et al. J Clin Endocrinol Metab. 2006;91(3):799-805. PMID 16352683 · DOI 10.1210/jc.2005-1536
- IpamorelinHuman RCT
- What it is
- A lab-made peptide that mimics ghrelin and prompts growth hormone release.
- Used for
- Researchers studied it in slowed bowel function after surgery (postoperative ileus). It is not an approved medicine.
- Studied for
- Time to return of bowel function after surgery (human RCT; no difference from placebo)
- Tolerability after bowel surgery (human RCT)
- Made of
- 5 building blocks, three of them non-standard amino acids.
- What research found
- In a phase 2 trial of 117 adults after bowel surgery, researchers reported no significant difference from placebo in time to tolerating a solid meal (median 25.3 vs 32.6 hours); it was well tolerated. This was a negative result on the main measure.
- Status
- Not approved for human use in the US.
Beck DE, et al. Int J Colorectal Dis. 2014;29(12):1527-1534. PMID 25331030 · DOI 10.1007/s00384-014-2030-8
- KisspeptinHuman pilot
- What it is
- A natural hormone that switches on the reproductive hormone chain at the brain level.
- Used for
- Researchers study it in fertility medicine, including egg maturation during IVF.
- Studied for
- Egg maturation during IVF (human pilot)
- Ovarian hyperstimulation rates during IVF (human pilot)
- Made of
- Several natural forms; this study used kisspeptin-54, a 54-amino-acid form.
- What research found
- In a phase 2 study of 60 women at high risk of ovarian hyperstimulation during IVF, randomized between doses with no placebo group, researchers reported egg maturation in 95% of women, live births in 45% of embryo transfers, and no moderate or severe hyperstimulation.
- Status
- Not approved for human use in the US.
Abbara A, et al. J Clin Endocrinol Metab. 2015;100(9):3322-3331. PMID 26192876 · DOI 10.1210/jc.2015-2332
- SelankHuman controlled trial
- What it is
- A lab-made peptide based on tuftsin, a small immune peptide.
- Used for
- Registered as a medicine in Russia for anxiety and related conditions. Not approved in the US.
- Studied for
- Anxiety symptoms (human controlled study vs medazepam)
- Fatigue (asthenia) (human controlled study)
- Made of
- 7 amino acids: the 4 amino acids of tuftsin plus a Pro-Gly-Pro tail.
- What research found
- In a Russian study of 62 patients with generalized anxiety disorder or neurasthenia, researchers reported anxiety-scale changes with Selank (30 patients) similar to those with the anxiety medicine medazepam (32 patients), and lower fatigue scores. The abstract does not describe randomization; the article is in Russian.
- Status
- Not approved for human use in the US.
Zozulia AA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48. PMID 18454096
- Thymosin alpha 1Human RCT
- What it is
- A natural immune-signaling peptide first found in the thymus gland.
- Used for
- Approved as a medicine in some countries outside the US, mainly in hepatitis B and C. Researchers have also studied it in sepsis.
- Studied for
- 28-day death rates in sepsis (human RCT; no clear difference)
- Other sepsis outcomes (human RCT; no significant difference)
- Made of
- 28 amino acids with a modified (acetylated) starting end.
- What research found
- In TESTS, a trial of 1,106 adults with sepsis at 22 centers in China, researchers reported no clear difference in 28-day death rates (23.4% vs 24.1% with placebo). This is a negative result.
- Status
- Not approved for human use in the US.
Wu J, et al. BMJ. 2025;388:e082583. PMID 39814420 · DOI 10.1136/bmj-2024-082583
Preclinical and early research
- MOTS-cAnimal and cell
- What it is
- A peptide encoded in mitochondrial DNA rather than in the cell nucleus.
- Used for
- Researchers study it in metabolism, insulin sensitivity and aging.
- Studied for
- Insulin sensitivity (mouse and cell studies)
- Diet-related weight gain (mouse studies)
- Made of
- 16 amino acids.
- What research found
- In mice and lab cells, researchers reported that MOTS-c acted mainly on muscle, and that treatment in mice prevented age-related and high-fat-diet-related insulin resistance and diet-induced obesity. No human outcomes were tested.
- Status
- Not approved for human use in the US.
Lee C, et al. Cell Metab. 2015;21(3):443-454. PMID 25738459 · DOI 10.1016/j.cmet.2015.02.009
- GHK-CuHuman controlled trial
- What it is
- A small natural peptide found in human blood, bound to copper.
- Used for
- Used as a cosmetic skin-care ingredient. Researchers have studied it in skin after cosmetic procedures.
- Studied for
- Redness and wrinkles after laser resurfacing (small human controlled trial; no objective difference)
- Patient-rated skin satisfaction (small human controlled trial)
- Made of
- 3 amino acids (glycine, histidine, lysine) bound to a copper ion.
- What research found
- In a small randomized study after laser skin resurfacing (13 patients completed), researchers reported no objective differences in redness, wrinkles or skin quality with GHK-Cu, but higher patient-rated satisfaction.
- Status
- Not approved as a drug in the US; injectable GHK-Cu is not approved for human use.
Miller TR, et al. Arch Facial Plast Surg. 2006;8(4):252-259. PMID 16847171 · DOI 10.1001/archfaci.8.4.252
- BPC-157Human pilot
- What it is
- A lab-made peptide its developers describe as a fragment of a stomach protein.
- Used for
- Researchers have studied it mainly in animal models of gut and tissue injury.
- Studied for
- Gut and tissue injury models (animal studies)
- Blood-marker changes after IV use (2-person human pilot; none found)
- Made of
- 15 amino acids; the parent protein has not been independently identified.
- What research found
- In an uncontrolled pilot at a private clinic, two adults who had used it before received it intravenously; researchers reported no measurable changes in heart, liver, kidney, thyroid or blood-sugar markers, and no side effects. Two participants cannot show what happens in a wider population.
- Status
- Not approved for human use in the US.
Lee E, Burgess K. Altern Ther Health Med. 2025;31(5):20-24. PMID 40131143
- KPVAnimal and cell
- What it is
- A three-amino-acid peptide from the tail end of the hormone alpha-MSH.
- Used for
- Researchers study it in models of intestinal inflammation, such as inflammatory bowel disease.
- Studied for
- Inflammatory signaling in gut and immune cells (lab cell studies)
- Colitis severity (mouse studies)
- Made of
- 3 amino acids: lysine, proline, valine.
- What research found
- In human lab cells, researchers reported that KPV entered cells through a gut transporter (PepT1) and reduced inflammatory signaling. In two mouse models of colitis, researchers reported lower inflammation in mice given KPV. No human outcomes were tested.
- Status
- Not approved for human use in the US.
Dalmasso G, et al. Gastroenterology. 2008;134(1):166-178. PMID 18061177 · DOI 10.1053/j.gastro.2007.10.026
- EpitalonCell
- What it is
- A lab-made peptide based on an extract of the pineal gland.
- Used for
- Researchers study it in relation to aging and telomeres, the protective caps on chromosomes.
- Studied for
- Telomere length (lab cell studies)
- Aging-related outcomes (not tested in people)
- Made of
- 4 amino acids: alanine, glutamic acid, aspartic acid, glycine.
- What research found
- In lab cells, researchers reported dose-dependent telomere lengthening in normal cells through increased telomerase, and telomere lengthening in two breast cancer cell lines through a different mechanism (alternative lengthening of telomeres); this is cell work and does not show effects in people.
- Status
- Not approved for human use in the US.
Al-Dulaimi S, et al. Biogerontology. 2025;26(5):178. PMID 40908429 · DOI 10.1007/s10522-025-10315-x
Unregulated market
- TB-500 / Thymosin beta 4Human RCT
- What it is
- Thymosin beta 4 is a natural peptide in nearly every cell; TB-500 is a short lab-made fragment of it sold online.
- Used for
- Researchers have studied thymosin beta 4 in heart and wound models and early trials. The cited study did not test TB-500.
- Studied for
- Heart and wound models (animal studies and early trials of thymosin beta 4)
- Tolerability in healthy volunteers (phase 1 human RCT of full-length thymosin beta 4)
- Made of
- Thymosin beta 4: 43 amino acids. TB-500: a 7-amino-acid fragment (LKKTETQ).
- What research found
- In a phase 1 trial, four groups of 10 healthy volunteers received intravenous full-length thymosin beta 4 or placebo, in single-dose and repeated-dose phases; researchers reported infrequent, mild to moderate side effects and no dose-limiting toxicity. This study did not test TB-500.
- Status
- Not approved for human use in the US.
Ruff D, et al. Ann N Y Acad Sci. 2010;1194:223-229. PMID 20536472 · DOI 10.1111/j.1749-6632.2010.05474.x
Peptide education connected to the full picture.
You will work directly with a personal trainer who brings academic training and years of coaching experience to every conversation, while medical decisions remain with your clinician.
- Education
- B.S. in Exercise Science / Human Performance Enhancement
- Experience
- 16 years as an athletic trainer
- Certifications
- NASM-CPT
- CCPT
- NASM CES
- NASM PES
- FMS
- CPR and First Aid